- Report
- June 2025
- 89 Pages
North America
From €3023EUR$3,450USD£2,608GBP
- Report
- July 2020
- 116 Pages
United States
- Report
- August 2023
- 1500 Pages
Global
From €7666EUR$8,750USD£6,615GBP
- Report
- August 2022
- 96 Pages
Global
From €4381EUR$5,000USD£3,780GBP
- Report
- April 2022
- 264 Pages
Global
From €5257EUR$6,000USD£4,536GBP
- Report
- July 2024
- 476 Pages
Global
From €4337EUR$4,950USD£3,742GBP
- Report
- August 2023
- 389 Pages
Global
From €3658EUR$4,175USD£3,157GBP
- Report
- May 2024
- 85 Pages
United States
From €1577EUR$1,800USD£1,361GBP
- Report
- June 2022
- 342 Pages
Global
From €3066EUR$3,500USD£2,646GBP
- Report
- December 2023
- 110 Pages
Global
From €4074EUR$4,650USD£3,516GBP
- Report
- March 2023
- 123 Pages
Global
From €2190EUR$2,500USD£1,890GBP
- Report
- December 2021
- 388 Pages
Global
From €3285EUR$3,750USD£2,835GBP
- Report
- January 2024
- 127 Pages
Europe
From €2585EUR$2,950USD£2,230GBP
- Report
- December 2023
- 116 Pages
Asia Pacific
From €1073EUR$1,225USD£926GBP
€2146EUR$2,450USD£1,852GBP
- Report
- July 2023
- 325 Pages
Global
From €2409EUR$2,750USD£2,079GBP
€4819EUR$5,500USD£4,158GBP
- Report
- July 2023
- 284 Pages
Global
From €2409EUR$2,750USD£2,079GBP
€4819EUR$5,500USD£4,158GBP
- Report
- July 2023
- 227 Pages
Global
From €2409EUR$2,750USD£2,079GBP
€4819EUR$5,500USD£4,158GBP
- Report
- December 2022
- 109 Pages
Japan
From €1577EUR$1,800USD£1,361GBP
- Report
- May 2023
- 185 Pages
France
From €2620EUR$2,990USD£2,261GBP
- Report
- November 2022
- 190 Pages
Global
From €2182EUR$2,490USD£1,883GBP

The Epidemic market within the context of Biotechnology is a sector of the industry that focuses on the development of products and services to address the challenges posed by the spread of infectious diseases. This includes the development of vaccines, diagnostics, treatments, and other preventive measures. It also includes the development of technologies to monitor and track the spread of disease, as well as the development of public health policies and strategies to reduce the impact of epidemics.
The Epidemic market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to create new products and services. Companies in this market include Gilead Sciences, Moderna, Johnson & Johnson, Novavax, Inovio Pharmaceuticals, and Regeneron Pharmaceuticals. Show Less Read more